NCT05278858Phase 4Terminated early
Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata
Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata: a Pilot Study of Patient Tolerability
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Terminated early
- Declared phase
- Phase 4
- Sponsor
- University Hospitals Cleveland Medical Center
- Participants (registry)
- 3
- Start
- March 2022
- Primary completion
- June 2023
- Study completion
- June 2023
- Last registry update
- January 2024
- Countries
- United States
Conditions studied: Alopecia Areata
Interventions: MedJet Device with intralesional triamcinolone
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.